With these latest studies, the firmly established European market leader in stroke AI imaging adds to its growing body of evidence. The latest research reflects the company’s extensive academic collaborations and its growing Life Science partnerships. OXFORD, England and CHICAGO, May 16,…
Tag: Brainomix
Brainomix Targets US Expansion with the Launch of its Cutting-Edge Stroke AI Platform Following Series of FDA Clearances
Launched at the Society of Vascular and Interventional Neurology (SVIN) Conference in Miami, the Brainomix 360 platform is powered by best-in-class algorithms, delivering a unique technology for both specialist and non-specialist stroke centers that is poised to transform stroke care…
Brainomix Receives FDA Clearance for Its Flagship Stroke AI Imaging Software
The Oxford, UK headquartered company, long established as a market leader in Europe and a pioneer in the development of innovative stroke AI solutions, is now poised to take its transformative technology to US stroke centers OXFORD, England, and CHICAGO, March 21, 2023 /PRNewswire/ — Brainomix, the AI-powered medtech solutions company, today announced that its Brainomix 360 […]
Brainomix Technology Integrated into New UK Atrial Fibrillation Study
The study will assess the role of Huawei’s wearable technology to detect atrial fibrillation in post-stroke patients OXFORD, England, Feb. 22, 2023 /PRNewswire/ — Brainomix has announced its involvement in a new study sponsored by the University of Liverpool focused on post-stroke atrial fibrillation (AF). Sites with existing clinical deployments of Brainomix’s e-Stroke platform will […]
Brainomix announces the CE Mark certificate for the new e-CTA software
OXFORD, England, May 11, 2018 / PRNewswire / – e-CTA pro provides fast automated collateral evaluations that use IA and big data and are based on CTA analysis Brainomix, a medical imaging software company that uses artificial intelligence (AI) for rapid diagnosis and treatment of stroke victims, has received CE Mark approval for its new e-CTA […]
Recent
Ancora Heart Inc. Reports Two-Year Results Demonstrating Sustained Benefits of AccuCinch® System in Heart Failure Patients
Cardiawave Strengthens Leadership with Appointment of Jonathan Freeman as Board Chairman
AngioInsight Appoints Medtech Veteran Shlomi Nachman to Board of Directors; Announces Series A Round to Accelerate AI-Driven Advancement in Cardiology
Popular
- No commented posts yet